Zeria Pharmaceutical Co Ltd (4559.T)
23 Mar 2018
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|76||2014||Chairman of the Board, Chief Executive Officer, Representative Director|
|46||2014||President, Chief Operating Officer, Representative Director|
|64||2016||Vice President, Chief Director of Administration, Director of Human Resources, Director of Legal Affairs, Director|
|64||2014||Managing Director, Chief Director of Production & Logistics|
|54||2017||Chief Director of Consumer Health Care Sales, Manager of Beauty Care Sales Promotion Office, Director|
- BRIEF- Zeria Pharmaceutical buys back 113,900 shares for 236.5 mln yen in February
- BRIEF-Zeria Pharmaceutical says extension of share repurchase period
- BRIEF-Zeria Pharmaceutical buys back 150,900 shares for 345.4 mln yen in January
- BRIEF-Zeria Pharmaceutical buys back 32,000 shares for 66.9 mln yen
- BRIEF-Zeria Pharmaceutical buys back 39,100 shares for 82.3 mln yen